Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

ONC

Oncolytics Biotech (ONC)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:ONC
DataOraFonteTitoloSimboloCompagnia
26/09/202314:00PR Newswire (US)THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSTSX:ONCOncolytics Biotech Inc
01/06/202218:23PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONC.WTTSX:ONCOncolytics Biotech Inc
01/06/202218:21PR Newswire (Canada)IIROC Trading Halt - ONC.WTTSX:ONCOncolytics Biotech Inc
10/01/202217:57PR Newswire (US)New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024TSX:ONCOncolytics Biotech Inc
09/04/202117:56PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
09/04/202117:56PR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
09/04/202117:53PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
09/04/202117:52PR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
27/12/201713:00PR Newswire (US)Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patien...TSX:ONCOncolytics Biotech Inc
05/12/201713:00PR Newswire (US)Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic B...TSX:ONCOncolytics Biotech Inc
04/12/201713:00PR Newswire (US)Oncolytics Biotech® to Present at the Oncolytic Virotherapy SummitTSX:ONCOncolytics Biotech Inc
30/11/201713:00PR Newswire (US)Oncolytics Biotech® Establishes Scientific Advisory Board Focused on REOLYSIN® Registration Study in Metastatic Breast Canc...TSX:ONCOncolytics Biotech Inc
16/11/201723:00PR Newswire (Canada)Oncolytics Biotech® Inc. and Adlai Nortye Enter into USD $86.6 Million Regional Licensing Agreement for REOLYSIN®TSX:ONCOncolytics Biotech Inc
08/11/201713:00PR Newswire (US)Oncolytics Biotech® Inc. Announces 2017 Third Quarter ResultsTSX:ONCOncolytics Biotech Inc
02/11/201712:00PR Newswire (US)Oncolytics Biotech® Appoints Deborah Brown to Board of DirectorsTSX:ONCOncolytics Biotech Inc
11/10/201713:00PR Newswire (US)Oncolytics Biotech® to Present at the 2017 BIO Investor ForumTSX:ONCOncolytics Biotech Inc
19/09/201713:00PR Newswire (US)Oncolytics Biotech® to Present at the Phacilitate Immuno-Oncology Frontiers ConferenceTSX:ONCOncolytics Biotech Inc
18/09/201713:00PR Newswire (US)Oncolytics Biotech® Announces Successful End-of-Phase 2 Meeting with FDA for REOLYSIN® in Metastatic Breast CancerTSX:ONCOncolytics Biotech Inc
14/09/201713:00PR Newswire (US)Oncolytics Biotech® Announces First Patient Treated in MUK eleven StudyTSX:ONCOncolytics Biotech Inc
11/09/201713:00PR Newswire (US)Oncolytics Biotech® Announces the Presentation of REOLYSIN® Clinical Data at ESMO 2017 CongressTSX:ONCOncolytics Biotech Inc
03/08/201713:00PR Newswire (US)Oncolytics Biotech® Inc. Announces 2017 Second Quarter ResultsTSX:ONCOncolytics Biotech Inc
01/08/201713:00PR Newswire (US)Oncolytics Biotech® Inc. to Present at the Canaccord Genuity 37th Annual Growth ConferenceTSX:ONCOncolytics Biotech Inc
26/07/201713:00PR Newswire (US)Oncolytics Biotech® to Present REOLYSIN® Safety Data in combination with chemotherapy at ESMO 2017 CongressTSX:ONCOncolytics Biotech Inc
29/06/201713:00PR Newswire (Canada)Oncolytics® Biotech Inc. Appoints Andrew de Guttadauro, President of Oncolytics Biotech (U.S.) Inc.TSX:ONCOncolytics Biotech Inc
27/06/201713:00PR Newswire (US)Oncolytics Biotech® Inc. Opens U.S. Based Office in San DiegoTSX:ONCOncolytics Biotech Inc
01/06/201715:44PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONC.WTTSX:ONCOncolytics Biotech Inc
01/06/201715:43PR Newswire (Canada)IIROC Trade Resumption - ONC.WTTSX:ONCOncolytics Biotech Inc
01/06/201715:27PR Newswire (US)Oncolytics Biotech® Announces Closing of Public Offering of UnitsTSX:ONCOncolytics Biotech Inc
24/05/201716:39PR Newswire (US)Oncolytics Biotech® Prices Public Offering of UnitsTSX:ONCOncolytics Biotech Inc
24/05/201701:09PR Newswire (US)Oncolytics Biotech® Announces Proposed Public OfferingTSX:ONCOncolytics Biotech Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:ONC
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network